2
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
6
Observational
1
Expanded_access
1
Sponsor
Conditions
Breast Neoplasms
2934
Neoplasms
2633
Lung Neoplasms
1370
Colorectal Neoplasms
1332
Prostatic Neoplasms
1216
Carcinoma, Non-Small-Cell Lung
1080
Carcinoma, Hepatocellular
783
Stomach Neoplasms
721
Pancreatic Neoplasms
704
Ovarian Neoplasms
586
Colonic Neoplasms
534
Uterine Cervical Neoplasms
497
Head and Neck Neoplasms
496
Rectal Neoplasms
472
Melanoma
467
Multiple Myeloma
463
Esophageal Neoplasms
422
Neoplasm Metastasis
418
Brain Neoplasms
405
Lymphoma
399
Precursor Cell Lymphoblastic Leukemia-Lymphoma
398
Urinary Bladder Neoplasms
387
Leukemia, Myeloid, Acute
387
Leukemia
339
Carcinoma, Renal Cell
329
Liver Neoplasms
320
Endometrial Neoplasms
319
Hematologic Neoplasms
313
Recurrence
298
Disease
275
Interventions
Solutions
1
Cannabidiol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Lennox Gastaut Syndrome
×
Clear all
NCT05485831
2026-06-03
EpiTALY
Jazz Pharmaceuticals
Active not recruiting
111 enrolled